Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Ocrevus Zunovo (ocrelizumab & hyaluronidase-ocsq) Twice-A-Year Subcutaneous Injection for People With Relapsing and Progressive Multiple Sclerosis
September 13, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the United States Food and Drug Administration...
FDA Approves Ebglyss (lebrikizumab-lbkz) for the Treatment of Atopic Dermatitis
Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) approved Ebglyss (lebrikizumab-lbkz), a targeted IL-13...
FDA Approves First Flu Vaccine You Give Yourself at Home
The days of waiting for a flu shot at your doctor's office or local pharmacy may be over: The U.S. Food and Drug Administration on Friday approved FluMist...
High Levels of Well-Being Protect Against Cardiovascular Disease
High levels of well-being may protect against the risks for cardiovascular diseases (CVDs), according to a study published online Sept. 18 in the Journal...
In 2021, More Than 1 Million Deaths Attributed to Antimicrobial Resistance
From 1990 to 2021, the burden of antimicrobial resistance (AMR) decreased for those younger than 5 years and increased for those older than 70 years, according...
Behavior Change Intervention Via Mail Cuts Use of Sleep Medications in Older Adults
A mailed knowledge mobilization and behavior change intervention can reduce the use of sedatives and improve sleep outcomes in older adults with insomnia,...
Air Pollution Exposure Increases Risk for Parkinson Disease
Higher exposure to air pollution increases the risk for Parkinson disease (PD), according to a study published online Sept. 16 in JAMA Network Open.Brittany...
Stroke Rates Rising in Adults and Kids With Sickle Cell Disease
Stroke rates continue to rise among adults and children living with sickle cell disease, despite new standards of care meant to lower their risk, a new...
FDA Says Drug Makers Will Stop Producing Fentanyl 'Lollipops'
Controversial fentanyl lollipops and similar products will no longer be made by drug makers, the U.S. Food and Drug Administration has announced. Known...
U.S. Whooping Cough Cases Rising, Especially in Teens, CDC Says
Whooping cough cases are climbing at the fastest pace in years as students across America return to school, U.S. health officials reported Thursday. In...
Insilico Medicine Reports Positive Phase IIa Results for ISM001-055, a Novel First-in-Class Drug Treatment for Idiopathic Pulmonary Fibrosis (IPF) Designed Using Generative AI
CAMBRIDGE, Mass., Sept. 18, 2024. Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, announced positive preliminary results...
Bionpharma Inc. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension Due to Bacterial Contamination
September 17, 2024 – Princeton, NJ, Bionpharma Inc. is voluntarily recalling (1) single Batch (2310083) of Atovaquone Oral Suspension, 750mg per...
Ascletis Enters the Obesity Drug Space with Announcement of Two Ongoing U.S. Phase I Clinical Trials Utilizing Its Small Molecule GLP-1R Agonist ASC30
HONG KONG, Sept. 17, 2024. Ascletis Pharma Inc. ("Ascletis") announces today completion of initial dosing in its two recently initiated U.S. Phase I clinical...
Why Beans Are a Natural Superfood
Beans may sometimes give you gas, but one expert says that shouldn't stop you from finding ways to include them in your diet. Why? Because they are packed...
Recently Added
Recently added consumer and prescribing information: Pavblu, Livdelzi, Yorvipath, Crexont, Lymphir, Epysqli, Pyzchiva, Ahzantive, Ohtuvayre, Sofdra
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Ocrevus Zunovo Ocrevus Zunovo (ocrelizumab & hyaluronidase-ocsq) is a CD20-directed cytolytic antibody and hyaluronidase combination used for the...
- Ebglyss Ebglyss (lebrikizumab-lbkz) is a targeted IL-13 inhibitor used for the treatment of moderate-to-severe atopic dermatitis (eczema) in adults...
- Pavblu Pavblu (aflibercept-ayyh) is a vascular endothelial growth factor (VEGF) inhibitor biosimilar to Eylea indicated for the treatment of...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...